Cargando…
New drug regulations in France: what are the impacts on market access? Part 1 – Overview of new drug regulations in France
Access to the French drug market is being impacted by an ongoing dramatic shift in practice as well as by two laws that came into force in December 2011. This new environment has been described and analyzed in two separate articles. The first article aims to describe the recent changes in access to...
Autores principales: | Rémuzat, Cécile, Toumi, Mondher, Falissard, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865743/ https://www.ncbi.nlm.nih.gov/pubmed/27226825 http://dx.doi.org/10.3402/jmahp.v1i0.20891 |
Ejemplares similares
-
New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry
por: Rémuzat, Cécile, et al.
Publicado: (2013) -
Market access pathways for cell therapies in France
por: Rémuzat, Cécile, et al.
Publicado: (2015) -
Current process and future path for health economic assessment of pharmaceuticals in France
por: Toumi, Mondher, et al.
Publicado: (2015) -
Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment
por: Toumi, Mondher, et al.
Publicado: (2017) -
Determinants of orphan drugs prices in France: a regression analysis
por: Korchagina, Daria, et al.
Publicado: (2017)